$KAVL bounce

KAVL has had a strong fall down to a long-term demand zone. High risk play but big bounce potential.

评论:

$400m before the FDA shenanigans. $40m expected afterwards.
Price drop from $5 to $0.50.
FDA shenanigans reversed.

$5 inc

评论:

Boom

评论:

Bout time for another bounce. Hard floor at 10 cents.